IL21 and Graves disease: Furthermore, genetically higher plasma levels of IL‐21 and MICB are associated with an elevated risk of digestive disorders such as intestinal malabsorption and endocrine metabolic disorders including Type 1 diabetes, thyrotoxicosis with or without goiter, and Graves' disease.